Making prescriptions personal

HEADQUARTERS FOUNDED WEBSITE

Minneapolis, MN December 2013 by oneome.com
Invenshure & Mayo Clinic

LABORATORY EMPLOYEES PROVIDER PORTAL

Minneapolis, MN 35 and growing portal.oneome.com

Mission
We are committed to delivering the most cost-effective, comprehensive, clinically
actionable pharmacogenomic (PGx) testing and tools for all providers and patients
worldwide.

Principles
Strong, clinically relevant scientific data and healthcare leadership forms the core of
our business.

Fact We believe that partnering with providers will increase awareness and knowledge of
genomic medicine, which will ultimately benefit all patients. Thus, seamless
integration into providers’ current workflow is essential.

We’re driven by the knowledge that our company can affect the health and

sheet well-being of everyone in the world. As a result, we must:

be passionate about listening to our providers and patients

obsess about keeping our costs as low as possible without

jeopardizing quality

always do the right thing for the right reasons

Values
Our values are part of our DNA. They guide the way we work with providers,
patients, partners, and with each other.

By being accountable, trustworthy, creative, passionate, humble, and results-driven,

we have created a vibrant company culture where ideas can blossom, people can
thrive, and success can flourish.

Strategic initiatives
Become the most cost-effective, comprehensive, pharmacogenomic
solution backed by the strongest clinical evidence

Provide friendly, actionable clinical results to every healthcare

provider and patient

Ensure results are always accessible as patients transition

through the health system at different points of care
The OneOme solution — the RightMed® comprehensive test
Recent studies have demonstrated that > 90% of patients possess clinically actionable genetic variants that affect
their drug response.1,2 The RightMed test, beta launched in July 2016 and fully released in January 2017, identifies
which inherited genetic variations a patient has and determines how those variations may affect his/her response to
medications. With the RightMed reports and tools, providers may make more informed, evidence-based
prescription decisions and avoid medication trial and error.

THE RIGHTMED TEST IS:

a pharmacogenomic (medication response) test

an end-to-end solution, including a DNA collection test kit, PGx testing laboratory services,
data analysis, clinical reports, and interactive reporting tools

cost-effective, comprehensive, and backed by Mayo Clinic scientific team

accessible, with direct patient pay, insurance bill, or institution payment accepted

27 GENES HUNDREDS 30 4
COMPREHENSIVE PANEL OF MEDICATIONS MEDICAL INDICATIONS DAY AVERAGE TAT

Leadership & advisors

CO-FOUNDER CO-FOUNDER CO-FOUNDER
John L. Black, MD Liewei Wang, MD, PhD Richard Weinshilboum, MD
Mayo Clinic Mayo Clinic Mayo Clinic

CEO ADVISORY BOARD ADVISORY BOARD

Paul Owen MEMBER MEMBER
OneOme Paldeep S. Atwal, M.B., Christopher Bojrab, MD
Ch.B. Indiana Health Group
The Atwal Clinic

ADVISORY BOARD ADVISORY BOARD ADVISORY BOARD

MEMBER MEMBER MEMBER
Carmen Kosicek, MSN, Jeanette McCarthy, Dragan Primorac,
PMHNP MPH, PhD MD, PhD
Alay Health Team Precision Medicine St. Catherine’s
Advisors Specialty Hospital

ADVISORY BOARD ADVISORY BOARD

MEMBER MEMBER
Scott A. Storrer, MBA Steven Tucker, MD, FACP,
Affinity eHealth FAMS
Tucker Medical

1. Van Driest, SL, et. al., Clin Pharmacol Ther. 2014; 95(4): 423–431. 2. Yuan, J. et. al., Jmol Diag. 2016; 18(3): 438-445.
F-104-8